The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
Atrial fibrillation (AF) is the most frequently observed cardiac arrhythmia in clinical settings. Obesity can influence the efficacy of the treatment administered, which requires a larger dose and more time to...
Source: BMC Cardiovascular Disorders - Category: Cardiology Authors: Sohil Elfar, Somaya Abdulbaset Mahmoud, Samar Hamdi, Aya Ahmed Emad, Mohamed Abd-ElGawad and Nouran A. Taha Tags: Research Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Cardiac Arrhythmia | Cardiology | Cardiovascular | Eating Disorders & Weight Management | Heart | Obesity